FDA Adverse Event Malfunction Summary report: N

SFX SPI PDS+ UNI VIO 12IN 0 S/A CT-1

MDR report key: 13407745 · Received February 1, 2022

Report

Report Number
2210968-2022-00761
Event Type
Malfunction
Date Received
February 1, 2022
Date of Event
January 6, 2022
Report Date
January 31, 2022
Manufacturer
ETHICON INC.
Product Code
NEW
UDI-DI
10705031236219
PMA / PMN Number
K182873
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT # (B)(4). TO DATE THE DEVICE HAS NOT BEEN RETURNED. IF THE DEVICE OR FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. A MANUFACTURING RECORD EVALUATION WAS PERFORMED FOR THE FINISHED DEVICE LOT, AND NO NON-CONFORMANCES WERE IDENTIFIED. TRADE NAME - IRGACARE®, ACTIVE INGREDIENT(S) ¿ TRICLOSAN, DOSAGE FORM ¿ SUTURE/SOLID/PARENTERAL, STRENGTH ¿ 2360 G/M. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT UNDERWENT A TOTAL LAPAROSCOPIC HYSTERECTOMY PROCEDURE ON (B)(6) 2022 AND BARBED SUTURE WAS USED. THE SUTURE BROKE AT THE 2ND BACKSTITCH ON THE VAGINAL STUMP DURING CONTINUOUS SUTURING. NO ADVERSE PATIENT CONSEQUENCES WERE REPORTED. ADDITIONAL INFORMATION WAS REQUESTED

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1085058 SFX SPI PDS+ UNI VIO 12IN 0 S/A CT-1 SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE NEW ETHICON INC. SXPP1B450 RHBAPX 10705031236219

Patients

Seq Age Sex Outcome Treatment
1 Unknown